Home / Tag: Tecentriq

Tag Archives: Tecentriq

FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® Priority Review In Additional Type of Advanced Bladder Cancer

San Francisco CA— Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), recently announced that the U.S. Food and Drug Administration (FDA) has accepted the ...

Read More »